Myriad Genetics Inc MYGN
$3.36
+5.33%
at last close
Financials (TTM)
- Revenue
- $806.60 million
- Net Income
- $-112,600,000
- Net Margin
- -13.96%
- Return on Equity
- -37.05%
- Debt-to-Equity
- 0.40
- P/E Ratio
- —
- Price / Book
- 1.00
- Price / Sales
- 0.38
Over the trailing twelve months, Myriad Genetics Inc generated revenue of $806.60 million and net income of $-112,600,000, a net margin of -13.96%.
At the last closing price of $3.36, MYGN trades at 0.38 times sales, with a market capitalization of $305.12 million.
Key Stats
- Last Close
- $3.36
- Market Cap
- $305.12 million
- 52-Week Range
- $2.74 – $8.59
- Average Volume
- 2.44 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.